vs

Side-by-side financial comparison of INTERGROUP CORP (INTG) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $13.3M, roughly 1.3× OCULAR THERAPEUTIX, INC). INTERGROUP CORP runs the higher net margin — 8.8% vs -488.0%, a 496.7% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -22.4%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-57.1M). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs -5.3%).

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

INTG vs OCUL — Head-to-Head

Bigger by revenue
INTG
INTG
1.3× larger
INTG
$17.3M
$13.3M
OCUL
Growing faster (revenue YoY)
INTG
INTG
+42.2% gap
INTG
19.8%
-22.4%
OCUL
Higher net margin
INTG
INTG
496.7% more per $
INTG
8.8%
-488.0%
OCUL
More free cash flow
INTG
INTG
$56.6M more FCF
INTG
$-481.0K
$-57.1M
OCUL
Faster 2-yr revenue CAGR
INTG
INTG
Annualised
INTG
7.8%
-5.3%
OCUL

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
INTG
INTG
OCUL
OCUL
Revenue
$17.3M
$13.3M
Net Profit
$1.5M
$-64.7M
Gross Margin
88.0%
Operating Margin
11.6%
-526.5%
Net Margin
8.8%
-488.0%
Revenue YoY
19.8%
-22.4%
Net Profit YoY
155.6%
-33.6%
EPS (diluted)
$0.71
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTG
INTG
OCUL
OCUL
Q4 25
$17.3M
$13.3M
Q3 25
$17.9M
$14.5M
Q2 25
$16.2M
$13.5M
Q1 25
$16.8M
$10.7M
Q4 24
$14.4M
$17.1M
Q3 24
$16.9M
$15.4M
Q2 24
$13.4M
$16.4M
Q1 24
$14.9M
$14.8M
Net Profit
INTG
INTG
OCUL
OCUL
Q4 25
$1.5M
$-64.7M
Q3 25
$-535.0K
$-69.4M
Q2 25
$-2.2M
$-67.8M
Q1 25
$-578.0K
$-64.1M
Q4 24
$-2.7M
$-48.4M
Q3 24
$-398.0K
$-36.5M
Q2 24
$-4.9M
$-43.8M
Q1 24
$-3.2M
$-64.8M
Gross Margin
INTG
INTG
OCUL
OCUL
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
INTG
INTG
OCUL
OCUL
Q4 25
11.6%
-526.5%
Q3 25
15.3%
-472.3%
Q2 25
8.1%
-502.6%
Q1 25
14.0%
-597.5%
Q4 24
5.9%
-296.1%
Q3 24
18.5%
-298.2%
Q2 24
3.7%
-265.1%
Q1 24
4.8%
-214.0%
Net Margin
INTG
INTG
OCUL
OCUL
Q4 25
8.8%
-488.0%
Q3 25
-3.0%
-477.3%
Q2 25
-13.9%
-503.9%
Q1 25
-3.4%
-598.7%
Q4 24
-18.9%
-283.3%
Q3 24
-2.4%
-236.6%
Q2 24
-36.7%
-266.3%
Q1 24
-21.3%
-438.9%
EPS (diluted)
INTG
INTG
OCUL
OCUL
Q4 25
$0.71
$-0.27
Q3 25
$-0.25
$-0.38
Q2 25
$-0.39
Q1 25
$-0.27
$-0.38
Q4 24
$-1.26
$-0.25
Q3 24
$-0.18
$-0.22
Q2 24
$-0.26
Q1 24
$-1.44
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTG
INTG
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$7.5M
$737.1M
Total DebtLower is stronger
$233.2M
Stockholders' EquityBook value
$-85.2M
$654.3M
Total Assets
$101.1M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTG
INTG
OCUL
OCUL
Q4 25
$7.5M
$737.1M
Q3 25
$6.0M
$344.8M
Q2 25
$6.1M
$391.1M
Q1 25
$4.8M
$349.7M
Q4 24
$15.4M
$392.1M
Q3 24
$12.2M
$427.2M
Q2 24
$11.6M
$459.7M
Q1 24
$19.5M
$482.9M
Total Debt
INTG
INTG
OCUL
OCUL
Q4 25
$233.2M
Q3 25
$237.8M
Q2 25
$240.5M
Q1 25
$241.5M
Q4 24
$227.2M
Q3 24
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
INTG
INTG
OCUL
OCUL
Q4 25
$-85.2M
$654.3M
Q3 25
$-86.7M
$258.2M
Q2 25
$-86.1M
$305.9M
Q1 25
$-84.5M
$265.9M
Q4 24
$-83.9M
$315.3M
Q3 24
$-80.9M
$352.0M
Q2 24
$-80.3M
$377.7M
Q1 24
$-76.4M
$408.0M
Total Assets
INTG
INTG
OCUL
OCUL
Q4 25
$101.1M
$808.1M
Q3 25
$102.5M
$410.9M
Q2 25
$104.1M
$451.3M
Q1 25
$103.2M
$405.9M
Q4 24
$110.6M
$457.9M
Q3 24
$109.3M
$490.4M
Q2 24
$107.8M
$517.1M
Q1 24
$119.0M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTG
INTG
OCUL
OCUL
Operating Cash FlowLast quarter
$-23.0K
$-54.2M
Free Cash FlowOCF − Capex
$-481.0K
$-57.1M
FCF MarginFCF / Revenue
-2.8%
-430.9%
Capex IntensityCapex / Revenue
2.6%
21.4%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$739.0K
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTG
INTG
OCUL
OCUL
Q4 25
$-23.0K
$-54.2M
Q3 25
$-296.0K
$-50.7M
Q2 25
$5.9M
$-55.2M
Q1 25
$-854.0K
$-44.7M
Q4 24
$-781.0K
$-39.4M
Q3 24
$3.4M
$-36.6M
Q2 24
$6.8M
$-24.8M
Q1 24
$1.9M
$-33.9M
Free Cash Flow
INTG
INTG
OCUL
OCUL
Q4 25
$-481.0K
$-57.1M
Q3 25
$-1.3M
$-56.7M
Q2 25
$3.6M
$-56.5M
Q1 25
$-1.2M
$-46.6M
Q4 24
$-1.1M
$-39.6M
Q3 24
$3.1M
$-36.6M
Q2 24
$2.7M
$-25.5M
Q1 24
$1.1M
$-34.1M
FCF Margin
INTG
INTG
OCUL
OCUL
Q4 25
-2.8%
-430.9%
Q3 25
-7.1%
-390.0%
Q2 25
22.5%
-419.7%
Q1 25
-6.8%
-435.6%
Q4 24
-7.8%
-232.0%
Q3 24
18.3%
-237.6%
Q2 24
20.4%
-155.4%
Q1 24
7.6%
-231.1%
Capex Intensity
INTG
INTG
OCUL
OCUL
Q4 25
2.6%
21.4%
Q3 25
5.4%
41.2%
Q2 25
13.9%
9.3%
Q1 25
1.8%
18.1%
Q4 24
2.4%
1.2%
Q3 24
1.6%
0.6%
Q2 24
30.4%
4.5%
Q1 24
4.9%
1.7%
Cash Conversion
INTG
INTG
OCUL
OCUL
Q4 25
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

OCUL
OCUL

Segment breakdown not available.

Related Comparisons